about
An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients.Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation CarriersPolyneuropathy while on duodenal levodopa infusion in Parkinson's disease patients: we must be alert.Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion.Progressive presynaptic dopaminergic deterioration in Huntington disease: a [123I]-FP-CIT SPECT two-year follow-up study.Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers.Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: impact on control of fluctuations and quality of life.Novel SCN1A mutation in the IFMT motif of the α1 subunit of the voltage-gated NaV1.1 channel causing familial hemiplegic migraine.[Movement disorders units and management of motor fluctuations in advanced Parkinson's disease].[Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease].Remote control of apomorphine infusion rate in Parkinson's disease: Real-time dose variations according to the patients' motor state. A proof of concept.Direct sequencing of the human protamine P1 gene and application in forensic medicineAmmonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series
P50
Q33890861-E888CD1F-692D-4707-B8DB-D7D83E8E9953Q35692655-B6463EAB-2868-40A2-9E2D-9A762D72E30AQ37978131-6CFC9F42-CD42-4344-A479-8BD9E34DD754Q38371848-DCB98280-61F3-466A-AFA5-A488F92AC49EQ39444731-F33CA160-085B-4845-996D-B8B43C8F1A09Q40608804-4E08F9F2-72BE-4A66-8559-1677AC9CD2EEQ43275163-C71721EB-A122-4AB6-A4C8-5BE235BE366BQ46178430-BE902956-DC4F-4537-8460-A4460BF34C66Q50086643-B1400215-581A-40BC-ABB8-D40CD2577B82Q53459179-BAD853D3-DA09-4262-9ED5-EC996CFE30C9Q53496756-E8AA4BFC-C77F-40B7-BF12-711E079F122EQ72663307-F4B8529A-E5A7-451C-9697-327AF6B3DEEAQ90581637-A7BAB4D2-0AB0-4F3B-897D-91DC5958080D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Oriol de Fabregues
@ast
Oriol de Fabregues
@en
Oriol de Fabregues
@es
Oriol de Fabregues
@nl
type
label
Oriol de Fabregues
@ast
Oriol de Fabregues
@en
Oriol de Fabregues
@es
Oriol de Fabregues
@nl
prefLabel
Oriol de Fabregues
@ast
Oriol de Fabregues
@en
Oriol de Fabregues
@es
Oriol de Fabregues
@nl
P106
P31
P496
0000-0002-3518-5338